FOX 66 News at Ten
Story by Marilynn Marchione / ASSOCIATED PRESS
suggests that a shot every one to three months may someday give an
alternative to the daily pills that some people take now to cut their
risk of getting HIV.
The experimental drug has only been tested
for prevention in monkeys, but it completely protected them from
infection in two studies reported at an AIDS conference on Tuesday.
is the most exciting innovation in the field of HIV prevention that
I've heard recently," said Dr. Robert Grant, an AIDS expert at the
Gladstone Institutes, a foundation affiliated with the University of
California, San Francisco.
"Both groups are showing 100 percent
protection" with the drug, Grant said of the two groups of researchers.
"If it works and proves to be safe, it would allow for HIV to be
prevented with periodic injections, perhaps every three months."
a vaccine is developed, condoms are the best way to prevent infection
with the AIDS virus and many other sexually spread diseases. But not
everyone uses them, or does so all the time, so public health officials
have pursued other prevention options.
A drug used to treat
people with HIV — Gilead Science's Truvada — also is used to help
prevent infection in people who don't have the virus. A big study in gay
men a few years ago found it could cut this risk by up to 90 percent,
depending on how faithfully people take the daily pills.
research tested something that could make this type of prevention much
more practical — a long-acting experimental drug made by GlaxoSmithKline
PLC. The studies tested it in macaques exposed to a human-monkey
version of HIV.
Researchers at the Centers for Disease Control
and Prevention gave six monkeys shots of the drug every four weeks; six
others got dummy shots. All were exposed to the virus twice a week for
The monkeys who got the fake treatment were readily
infected "but the animals that received the long-acting drug remained
protected," said study leader Gerardo Garcia-Lerma of the CDC.
results mirror what was seen in the CDC's early research in monkeys on
Truvada, the pill that's available for HIV prevention now.
second study, Chasity Andrews and others at the Aaron Diamond AIDS
Research Center at Rockefeller University in New York gave eight monkeys
two shots of the drug, four weeks apart, and dummy shots to eight
others. The animals were exposed to the virus weekly for eight weeks.
Again, all animals given the fake treatment were quickly infected and
those on the drug were all protected.
To see how long a single
shot would last, they did a second study. The single shot protected 12
monkeys for about 10 weeks on average.
The dose used in a single shot corresponded to what people would get from a shot every three months, researchers said.
is really promising," said Dr. Judith Currier, an infectious disease
specialist at the University of California, Los Angeles. The research
"supports moving this forward" into human testing, she said.
is on the program committee for the meeting in Boston where the studies
were presented — the Conference on Retroviruses and Opportunistic
Infections. The New York study also was published online by the journal
Grant said the long-acting drug is chemically similar to
certain AIDS medicines sold now that are "extremely safe, well
tolerated and extremely potent." A mid-stage trial testing the
long-acting shots in people as a treatment, not a prevention, is already
underway, he said.
Wednesday, March 5 2014, 09:18 AM EST
National News Headlines
|US fighter jets escort Air France flight to New York after reported threat|
|U.S. fighter jets were escorting Monday an Air France jet to New York’s John F. Kennedy Airport after an anonymous threat, WABC reported.|
|Pennsylvania teen ordered to tear down treehouse after neighbor complains|
|An ambitious Pennsylvania teen who built a deluxe two-story treehouse in her front yard has been ordered to tear it down after a neighbor complained.|
|11 Strategies to Change How You Email|
|Transform how you manage your inbox and change your life.|
|Vocabulary test takes away some National Spelling Bee drama|
|For viewers of last year's Scripps National Spelling Bee, one of the most surprising results came courtesy of a test nobody saw.|
|Why This MMA Startup Honors Its Military Fanbase|
|The founder and CEO of Fighters' Source also shares business lessons from the fight cage.|
|NJ community's ‘Field of Dreams’ flag project honors fallen veterans|
|A New Jersey community is covering all the bases this Memorial Day, honoring US veterans from the area who gave their lives fighting for America.|
|'We know that God is able': Student delivers powerful prayer at high school graduation|
|An Alabama high school graduation delivered a lot more than pomp and circumstance Thursday night when a medical emergency in the audience prompted one of the graduates to take to the podium and offer an extraordinary prayer that has garnered the teen nationwide attention.|
|Coast Guard in search for missing woman|
|The Coast Guard is searching Monday for a 26-year-old woman who vanished from a boat while sailing in Biscayne Bay, off Florida’s coast.|
|Relatives of people buried at troubled Tennessee cemetery to visit loved ones for 3 hours|
|Relatives of people buried at a troubled Memphis-area cemetery will have the opportunity to visit their deceased loved ones for the first time since the cemetery closed more than a year ago, after its owner was arrested and charged with mishandling bodies.|
|Couple missing for 2 weeks found in California wilderness|
|The search for a couple that vanished two weeks ago ended on Sunday after a man was found dead and a woman found severely dehydrated in a remote part of San Diego County, authorities said.|